Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05252871 · ClinicalTrials.gov registry record · NA

Assessment of Three Basic Progressive Lens Designs

A NA study of Presbyopia, sponsored by Western University of Health Sciences.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05252871 is a NA study of Presbyopia that has completed, run by Western University of Health Sciences. The registered enrollment target is 80 participants, below the 268-participant average among 38 other Presbyopia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05252871, a NA study of Presbyopia, has completed, sponsored by Western University of Health Sciences.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.

Conditions Studied

Interventions

  • DEVICE Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating

Study Locations (1)

California

  • Western University of Health Sciences - Pomona

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-12-09
Est. Completion 2022-06-06
Phase NA

What the Registry Record Tells You About NCT05252871

The ClinicalTrials.gov registry entry for NCT05252871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 38 other Presbyopia trials with a reported enrollment target (70% lower). The listed sponsor is Western University of Health Sciences, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 1 intervention - of which Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating is the first listed.

NCT05252871 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05252871 about?

NCT05252871 is a clinical study titled "Assessment of Three Basic Progressive Lens Designs". This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.

What is the current status of trial NCT05252871?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2021-12-09. Estimated completion is 2022-06-06.

What conditions does trial NCT05252871 study?

This clinical trial studies the following conditions: Presbyopia.

What interventions are being tested in trial NCT05252871?

The interventions under investigation include: Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating (DEVICE).

Who is sponsoring clinical trial NCT05252871?

This trial is sponsored by Western University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05252871 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.